The Valley Desk

ArticleFuture oncology (London, England)Published

Burden of illness among patients with relapsed or refractory multiple myeloma, and eligible for B-cell maturation antigen-targeted therapies

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Future oncology (London, England)
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Hospitalization; Retrospective Studies; Drug Resistance, Neoplasm; Cost of Illness; Adult; Aged; Aged, 80 and over; Middle Aged; Health Care Costs
PubMed ID
40471555
PubMed Central ID
PMC12239814
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal